Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/6034a251-2b1a-4168-b04d-a4758bd98ac3/

BNR

Burning Rock Biotech Ltd
Chart
9.97 USD
Latest Week 2026-07-17
Snapshot 2026-07-19 · 0.6w · Fresh
0.81
OS Score
78.0%
Value
14.0%
Quality
91.0%
Momentum
6/9
F-Score
0.330
QV
Strategy Eligibility
3 of 23 passing
OS Composite
OS 0.810
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
Yes
🔍
Small Cap Value
Val 78%
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
78.0%ile
P/S
0.2×
P/B
0.2×
FCF Yield
-0.276
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
14.00000000
/100 — 1=cheapest
VC2 (Trending Value)
22.00000000
/100
VC3 (Buyback)
24.00000000
/100
Negative FCF yield (-27.6%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
14.0%ile
ROE
-0.114
ROA
-0.075
Net Margin
-0.115
Op Margin
-0.101
GPA
0.485
D/E
0.53
Current
3.05
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.020
Stability
0.994
lower=better
Accruals
-0.032
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
91.0%ile
6M Return
-68.9%
12M Return
112.1%
12-1 Mom
54.3%
Risk-Adj
0.40
Vol 252d
137.2%
Vol 60d
296.4%
↑ Expanding
Max DD 12M
-79.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 54% is very strong — a clear uptrend. Near-term vol (296%) is expanding vs long-term (137%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.81
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
88.0%
Sector Quality %ile
2.2%
P/B z-score
-0.32
Sector Avg OS
64.0%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 96.0%
IRWD Ironwood Pharmaceuticals Inc 99.0% 92.0% 91.0% 98.0%
NUTX Nutex Health Inc 98.0% 91.0% 98.0% 80.0%
FBIO Fortress Biotech Inc 98.0% 98.0% 84.0% 88.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 90.0% 93.0% 93.0%
CGEN Compugen 98.0% 89.0% 96.0% 82.0%
TBPH Theravance Biopharma Inc 98.0% 90.0% 99.0% 84.0%
MD Mednax Inc 97.0% 85.0% 84.0% 93.0%
Factor Interactions
Trending Value Signal
Cheap (78th value) with strong momentum (91th). The market is starting to recognise the value.
Cheap for a Reason?
Looks cheap (78th value) but weak quality (14th). Classic value trap risk.
Hot but Volatile
Strong momentum (91th) but high volatility (137%). Momentum could reverse sharply.
Volatility Expanding
60-day vol (296%) significantly exceeds 252-day (137%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
52.8% avg (4 factors)
Quality
D
44.6% avg (8 factors)
Momentum
C
58.7% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.810—7
Value %ile0.780—7
Quality %ile0.140—7
Momentum %ile0.910—7
F-Score6.000—0
Confidence0.793—7
Volatility1.372—7
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
0.21
Price / Book
0.20
FCF Yield
-27.6%
Sales Yield (1/P·S)
4.8759
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-11.4%
Return on Assets
-7.5%
Net Margin
-11.5%
Operating Margin
-10.1%
Gross Profit / Assets
Novy-Marx GPA
48.5%
Debt / Equity
0.53
Current Ratio
3.05
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.032
MomentumPrice trend strength over different horizons
6M Return
-68.9%
12M Return
112.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
54.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.40
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-2.0%
Earnings Stability (CV)
Lower = more stable
0.994
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
14
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
22
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
24
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
Yes
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity